• Intestinal Parasitic Disease And Hygienic Conditions In Children- Diagnostic Evaluation For Prevention

    Oct 1, 2017, 00:00

  • Health Valuation of Dialysis with the EQ-5D- Determinants of Discrepancy Between Patients and Society

    Oct 1, 2017, 00:00

  • Pro Instruments Used in Studies of Skin Cancer Since 1960

    Oct 1, 2017, 00:00

  • A Predictive Model To Include Uncertainty In Mean Health Utilities Estimation- Impact Of Social Class, Body Mass Index And Chronic Diseases

    Oct 1, 2017, 00:00

  • Estudio De Costo-Efectividad E Impacto Presupuestal De Denosumab vs. Ácido Zoledrónico Para El Manejo De Metástasis Óseas En Pacientes Con Cáncer De Próstata En Colombia

    Oct 1, 2017, 00:00

  • Economic Burden Of Hospitalized Diarrheal Disease In Bangladesh

    Oct 1, 2017, 00:00

  • Willingness To Pay For Qaly In The Czech Republic Between 2013 And 2017- A Review

    Oct 1, 2017, 00:00

  • A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

    Oct 1, 2017, 00:00

  • Disease-Related Cost Burden In Patients Undergoing Sinus Surgery For Chronic Rhinosinusitis- A Claims-Based Analysis

    Oct 1, 2017, 00:00

  • How Much Sexual Violence Against Women Costs To Brazil?

    Oct 1, 2017, 00:00

  • Costo De La Diabetes Mellitus En El Sistema De Salud Colombiano

    Oct 1, 2017, 00:00

  • Evaluating The Real-Life Daily-Cost of Treatment With Antiepileptic Drugs In Fran A Study Based on The Combination Of French National Health Insurance Public Database, and The EMR LPD Private Database

    Oct 1, 2017, 00:00

  • Enhancement Program For Couples Adjustment To Failed Assisted Reproductive Technology

    Oct 1, 2017, 00:00

  • Coverage-With-Evidence-Development (CED) In Germany- Status QUO

    Oct 1, 2017, 00:00

  • Long Term Efficacy of Pertuzumab For HER2+ Metastasic Breast Cancer Ecuadorian Population

    Oct 1, 2017, 00:00

  • Anti-Thrombotic Therapy For Patients With Venous Thromboembolism In A Nationwide Health Plan

    Oct 1, 2017, 00:00

  • Burden of Genital Warts In Ecuador- An Observational Study

    Oct 1, 2017, 00:00

  • Impact of Isocitrate Dehydrogenase (IDH) Status on the Performance Status and Quality of Life (QOL) of Glioblastoma Multiforme (GBM) Patients

    Oct 1, 2017, 00:00

  • Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Inflectra® Vs. Remicade® for Ankylosing Spondylitis in Germany

    Oct 1, 2017, 00:00

  • Palliative Care Services In Romania- Analysis Of Utilization, Funding And Coverage

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life of Patients with Osteoporosis Treated with Teriparatide

    Oct 1, 2017, 00:00

  • The Epidemiology Of Adult Immune (Idiopathic) Thrombocytopenic Purpura (ITP) In Finland- Resource Utilisation, Related Costs And Hospital Medication Associated With The Treatment Of Non-Splenectomised Adult Itp Based On Real World Data From ...

    Oct 1, 2017, 00:00

  • Listening to the “Patient Voice” to Improve Design and Interpretation of Secondary Analyses- An Example in Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients- A Real-World Study In Sweden

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Economic Assessment of NT-PROBNP Test for Acute Heart Failure at Brazilian Private Payer Perspective

    Oct 1, 2017, 00:00

  • What Do The Single Technology Appraisals of The Past Tell US About Fast-Tracking The Most Cost-Effective New Technologies In The Future?

    Oct 1, 2017, 00:00

  • Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

    Oct 1, 2017, 00:00

  • Work Productivity in Brazilian Patients with Moderate-to-Severe Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Budget Impact of New Therapies for Metastatic Melanoma in Italy

    Oct 1, 2017, 00:00

  • Second-Line Treatments For Advanced Gastric Cancer- A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

    Oct 1, 2017, 00:00

  • Assessment of Medicines For Very Rare Conditions- Review of A New Approach within The Scottish Medicines Consortium

    Oct 1, 2017, 00:00

  • Variation Trend of Annual Medical Cost Forseveralkinds of Malignant Tumors in China- Analysis Based on A Regional Public Health Insurance Claim Database (2011-2015)

    Oct 1, 2017, 00:00

  • Impact of Different Baseline Definitions on The Incidence of Relevant Outcomes Associated with Cancer Following An Advanced Non-Small Cell Lung Cancer (NSCLC) Diagnosis

    Oct 1, 2017, 00:00

  • Quality of Life and Economic Burden Among Chronic Obstructive Pulmonary Disease (Copd) Patients in Japan

    Oct 1, 2017, 00:00

  • ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer- Clinical And Budget Impact

    Oct 1, 2017, 00:00

  • Cost-Savings In Process Innovations; A Case Example In Myocardial Infarction Patients

    Oct 1, 2017, 00:00

  • Hepatitis A and Hepatitis B Recombinant Vaccine Adherence In The United States

    Oct 1, 2017, 00:00

  • Identification of Assessment and Funding Models Applicable to Companion Diagnostics in UK, France And Germany

    Oct 1, 2017, 00:00

  • A Systematic Review Of Economic Evaluations In Robot-Assisted Hysterectomy Use For Cervical Cancer Compared With Open And Laparoscopic Surgery

    Oct 1, 2017, 00:00

  • Estimate European Candidates For Bronchoscopic Lung Volume Reduction (BLVR) Technologies In The Treatment Of Severe Emphysema

    Oct 1, 2017, 00:00

  • Análisis De La Relaciones De Mercado Entre El Seguro Obligatorio Y El Seguro Voluntario Para El Caso Colombiano

    Oct 1, 2017, 00:00

  • Lacosamide As First Line Treatment Option In Focal Epilepsy; A Cost-Utility Analysis for The Greek Healthcare System

    Oct 1, 2017, 00:00

  • Psoriasis Drugs in Europe - Market Access Decisions in Comparision Based on the Prismaccess Database

    Oct 1, 2017, 00:00

  • Clinical Comparison of First-Line Platin Chemotherapy Regimens In Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Using German Registry Data

    Oct 1, 2017, 00:00

  • Disclosure of Traditional and Complementary Medicine Used During Pregnancy and the Postpartum Period to Healthcare Providers

    Oct 1, 2017, 00:00

  • The Dynamics of Child Mental Health Care

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Repellent And Larvicidal Activity Of Thai Medicinal Plants Against Mosquitoes- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • The Personalised Reimbursement Models (Prm)- Real World Data Collection to Provide Innovative Pricing Solutions in France

    Oct 1, 2017, 00:00

  • Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Surgical Approaches Total HIP Arthroplasty

    Oct 1, 2017, 00:00

  • Indicators of Participation in Cervical Cancer Screening Among Romany Women

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Infliixmab and Adalimumab Compared with Conventional Therapy in Patients with Crohn Disease in the Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Predicting Budget Impact- A Mixed-Effects Model Approach

    Oct 1, 2017, 00:00

  • Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis- A Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Web App Estimating Cost Savings And Clinical Outcomes Of Blood Glucose Monitoring Program. Example From The UK

    Oct 1, 2017, 00:00

  • Cost Analysis Of Drug-Related Probelms In Saudi Arabia, Patient And Health Care Professional's Perspective

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Ayahuasca Treatment For Substance Use Disorder (SUD) Patients In A Peruvian Centre

    Oct 1, 2017, 00:00

  • Generic Competition and ITS Impact on Reference Pricing System and Medicnes Utilization in the Group of Sartans

    Oct 1, 2017, 00:00

  • Multiple Myeloma Patients’ Profile and Regimens Transitions in the Brazilian Private Health Sector

    Oct 1, 2017, 00:00

  • Patients Acknowledge Adaptation- The Case Of Amputees

    Oct 1, 2017, 00:00

  • Crosslinking to Corneal Keratoconus

    Oct 1, 2017, 00:00

  • One Year Cost Of Ischemic Stroke And Intracranial Hemorrage According To Disability For Atrial Fibrillation Patients In France

    Oct 1, 2017, 00:00

  • Evaluation Of Wearable Technology Use In Clinician Outcomes Assessment Studies

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States- Analysis Using 28-Month Overall Survival (OS) Data from Ch ...

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer Using EQ-5D-5L

    Oct 1, 2017, 00:00

  • The Economic Impact of Dietary Sodium Reduction In Canada

    Oct 1, 2017, 00:00

  • Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases- Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • A Robust, Reproducible Method For Evaluating The Suitability of Disparate Observational Databases for Pooled Analysis, Using The Omop Common Data Model

    Oct 1, 2017, 00:00

  • Non-Proportional Hazards in Network Meta-Analysis- Efficient Strategies for Model Building and Analysis

    Oct 1, 2017, 00:00

  • Comparing The Estimated Health And Economic Benefits Of Herpes Zoster (HZ) Vaccines In The UK

    Oct 1, 2017, 00:00

  • A Conceptual Yet Pragmatic Framework for Value-Based Agreements

    Oct 1, 2017, 00:00

  • Comparing The Healthcare Cost Utilization Of Paediatric Patients With Haemophilia A With And Without Inhibitors Treated At Instituto De Seguridad Social Del Estado De Mexico Y Municipios

    Oct 1, 2017, 00:00

  • Trucs And CAR-TS - The Emergence Of Io Cell Therapies

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis And Its Role In Assessment Of Profitability In Poland

    Oct 1, 2017, 00:00

  • Resultados De La Implementación De Una Estrategia Combinada De Educación Y Gestión De Pacientes En Centros De Atención Primaria De Argentina

    Oct 1, 2017, 00:00

  • Economic Evaluation of the Change from An Opportunistic Cervical Screening Program to an Organized Screening in Catalonia, Spain

    Oct 1, 2017, 00:00

  • Direct Costs Of Inflammatory Bowel Diseases Therapy In Poland - Nationwide Database Analysis

    Oct 1, 2017, 00:00

  • Economic and Humanistic Burden of Illness Amongst Diabetes Patients Experiencing Treatment Inertia

    Oct 1, 2017, 00:00

  • A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic

    Oct 1, 2017, 00:00

  • Skin Pain In Psoriasis

    Oct 1, 2017, 00:00

  • Epidemiology of Psoriasis In Colombia- A Governmental Database Analysis

    Oct 1, 2017, 00:00

  • Estimation of Prevalence In Rare Disease

    Oct 1, 2017, 00:00

  • Understanding Stakeholder Expectations for Patient Engagement- A Qualitative Survey

    Oct 1, 2017, 00:00

  • Differences In Labour Participation Between People Living With HIV And The General Population- Results From Spain Along The Business Cycle

    Oct 1, 2017, 00:00

  • Cost-Minimization of Adalimumab and Infliximab In Patients With Moderate To Severe Ulcerative Colitis Refractory To Conventional Therapy

    Oct 1, 2017, 00:00

  • Risky Business- What Factors Influence Decision-Maker’s Willingness to Pay for New Treatments on the Hospital Formulary?

    Oct 1, 2017, 00:00

  • German Amnog Benefit Assessment- The Type Of Appropriate Comparator Makes The Difference

    Oct 1, 2017, 00:00

  • Racial Differences In The Prevalence of Cognitive Impairments And Dementia, Utilization of Chemo-Immunotherapy and Mortality In Elderly Diffuse Large B-Cell Lymphoma Patients

    Oct 1, 2017, 00:00

  • Single Versus Multiple Inhalers in Patients with Chronic Obstructive Pulmonary Disease (COPD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Novel Biologics Versus Conventional Preventive Therapies In Migraine- A Framework for Economic Evaluation

    Oct 1, 2017, 00:00

  • Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC)- A Mixed Treatment Comparison (MTC)

    Oct 1, 2017, 00:00

  • Role of Chemotherapy In The Current Treatment of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Reducing Cognitive Burden In Discrete Choice Experiments

    Oct 1, 2017, 00:00

  • Are Accelerated Approval Mechanisms A Predictor To Early Access And Coverage? A Global Study Of Cancer Drugs

    Oct 1, 2017, 00:00

  • Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S

    Oct 1, 2017, 00:00

  • A Model To Predict Costs And Outcomes Associated With Hyperkalaemia In Patients With Chronic Kidney Disease Or Heart Failure

    Oct 1, 2017, 00:00

  • How Should We Value Orphan Drugs? Suggestions From A Large Public Opinion Survey

    Oct 1, 2017, 00:00

  • The Comparison of EQ-5D-5L Versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis

    Oct 1, 2017, 00:00

  • Assessing The Economic Impact Of The Introduction Of Daclatasvir In Combination With Asunaprevir For The Treatment Of Chronic Hepatitis C In China

    Oct 1, 2017, 00:00

  • New Drugs Approval Timing In Italy (2015-2017)

    Oct 1, 2017, 00:00

  • Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • The Economic Impact Of Fibrin Sealants Used For Hemostasis In Coronary Artery Bypass Grafting Surgery; An Italian Perspective

    Oct 1, 2017, 00:00

  • Evaluation of Anti-Asthmatic Potential of Artemisia Pallens Walls In Ovalbumin-Induced Airway Hyperresponsiveness in Laboratory Rats

    Oct 1, 2017, 00:00

  • Prescription Costs Associated with A Pediatrician-Led Care Model Serving Children with Medical Complexities (CMC)

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis At 48 Weeks from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility Interventions

    Oct 1, 2017, 00:00

  • Creating Individualized HBA1C Targets Using Predictive Modeling

    Oct 1, 2017, 00:00

  • Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007

    Oct 1, 2017, 00:00

  • The Impact of Disease Duration and Disease Activity on the Cost of Rheumatoid Arthritis- Results from Burden of Rheumatoid Arthritis Across Europe a Socioeconomic Survey (BRASS)

    Oct 1, 2017, 00:00

  • Amnog Dossiers As A Challenge for Pharmaceutical Companies- Is There A Correlation Between Volumes and Added Medical Benefit?

    Oct 1, 2017, 00:00

  • Comparison of Recent Hta Appraisals of Orphan Drugs By Nice, SMC And Has In 2015-2017

    Oct 1, 2017, 00:00

  • Estimating The Number of Relapsed And Refractory Indolent Lymphoma Patients Across Europe, Who Are Expected To Initiate A New Line of Therapy (LOT)

    Oct 1, 2017, 00:00

  • Burden Of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic Cardiovascular Disease (ASCVD) And The Impact Of Reducing Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Latin American ...

    Oct 1, 2017, 00:00

  • Iron Deficiency Anemia In Patients With Chronic Inflammatory Bowel Disease (IBD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Real World Comparison of Persistence And Adherence Among Biologic Naïve Patients Initiating Apremilast or Biologics for The Treatment of Psoriasis In The United States

    Oct 1, 2017, 00:00

  • Multi-Disciplinary Decision Making In General Practice- A Case Study Of Switching Between Oral Anticoagulants

    Oct 1, 2017, 00:00

  • Severity Of Kidney Disease In Systemic Lupus Erythematosus

    Oct 1, 2017, 00:00

  • Using Mathematical Optimisation In Model-Based Cost-Effectiveness Analyses- A Case Study Of A Stratified Breast Screening Programme

    Oct 1, 2017, 00:00

  • Costs of Managing Hypoglycaemias Among Insulin-Treated Patients with Diabetes- Results from the Hat Study in Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Potential Combined Vaccine Against Lyme Borreliosis And Tick-Borne Encephalitis In Slovenia

    Oct 1, 2017, 00:00

  • Merkel Cell Cancer- Poor Response To Chemotherapy Exposes Significant Unmet Need

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis For The Treatmet with Daclatasvir-Asunaprevir in Patients Naive with Chronic Hepatitis C Genotype 1b Without Baseline Ns5a Polymorphisms Under The Public Payer Perspective in Mexico

    Oct 1, 2017, 00:00

  • Characteristics of Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Are Patient Outcomes Being Relegated By Nices Budget Impact Test?

    Oct 1, 2017, 00:00

  • Systematic Literature Review On Multi-Indication Pricing Models In Oncological Drugs

    Oct 1, 2017, 00:00

  • Relative Efficacy and Tolerability of Lacosamide Versus Levetiracetam as Monotherapy for Adults with Newly Diagnosed Focal Seizures- A Post-Hoc Analysis of Randomized Clinical Trials

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Manufacturer Fees for Htas- Are They Promoting or Hindering Innovation?

    Oct 1, 2017, 00:00

  • Insight Into the Role of the General Practitioner in the Management of Colorectal Cancer- Record Linkage of the Netherlands Cancer Registry and the General Practitioner Database of the Pharmo Database Network

    Oct 1, 2017, 00:00

  • Assessing The Real-World Hospital Economic Burden Of Spinal Muscular Atrophy (SMA) In France

    Oct 1, 2017, 00:00

  • The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes

    Oct 1, 2017, 00:00

  • But Will They Trade Health? Developing An Economic Value Framework for Oncology

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Hospital Episode Statistics Data To Estimate The Economic Burden of Vaginal and Vulval Cancer in England (2009-2015)

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Enstilar® for The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • Efectividad De Las Intervenciones En Cultura De Seguridad Del Paciente En Las Instituciones Hospitalarias- Revisión Sistemática

    Oct 1, 2017, 00:00

  • Cost-Effectiveness And Impact Of New Innovative Treatments On Prognosis Of Melanoma And Ovarian Cancer For Australian Patients

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Lebanon- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • EQ-5D-5L Population Norms For Moscow (Russia)- Interim Analysis

    Oct 1, 2017, 00:00

  • Clinical And Economic Outcomes Of Microinvasive Glaucoma Surgery (MIGS) With Stents In Patients With Mild-To-Moderate Or Refractory Glaucoma In Spain

    Oct 1, 2017, 00:00

  • Improving Transparency In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Resource Utilization and Treatment of Patient with Hepatocelullar Carcinoma – A Microcosting Analysis

    Oct 1, 2017, 00:00

  • Seleção Sistemática De Coortes Em Bases De Dados Assistenciais

    Oct 1, 2017, 00:00

  • Does the Real-World use of Pharmacological Therapy Follow Guidelines in Coronary Artery Disease Patients in Finland?

    Oct 1, 2017, 00:00

  • Psoriatic Arthritis Limits Patients’ Ability to Contribute to Society As Part of the Workfor Results from A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Feasibility And Acceptability Of Atrial Fibrillation Screening Using A Hand-Held ECG Device In General Practice Setting In Hong Kong

    Oct 1, 2017, 00:00

  • Observed Versus Estimated Acquisition Costs Associated with Medicines Recommended by the All Wales Medicines Strategy Group

    Oct 1, 2017, 00:00

  • Can Missing Data Boundary Estimates Cast Doubt On Previous Conclusions Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)?

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Affective Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Modelling For Rare Diseases- Case of Canakinumab In Periodic Fever Syndromes In France

    Oct 1, 2017, 00:00

  • An Analysis of Health-Related Quality of Life in People with Multiple Sclerosis in Ireland

    Oct 1, 2017, 00:00

  • A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian Cancer

    Oct 1, 2017, 00:00

  • Dyslipidemia Treatment And CVD Risk In Adult Russians Who Reported Dyslipidemia

    Oct 1, 2017, 00:00

  • Broadening The Valuation Space In Health Technology Assessment- The Case of Monitoring Individuals With Ocular Hypertension

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location – A Time-Trade-Off Study in the United Kingdom General Population

    Oct 1, 2017, 00:00

  • Human Papilloma Virus In Italy- Cost Of Illness And Potential Savings Due To HPV9 Primary Prevention

    Oct 1, 2017, 00:00

  • Budget Impact of Ribociclib Plus Letrozole For The Treatment of Post-Menopausal Women With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2- Negative (HER2-) Advanced or Metastatic Breast Cancer From A US Private Th ...

    Oct 1, 2017, 00:00

  • Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data

    Oct 1, 2017, 00:00

  • Does The Early Bird Catch The Worm- Early Cancer Detection And Survival In The UK

    Oct 1, 2017, 00:00

  • Effect Of Pharmaceutical Care Intervention On Well-Being Index Of Type 2 Diabetes Outpatients In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Cost-Effectivenes Analysis of Anti-Tnf Use Compared To Dmards in The Fatal and Nonfatal Acute Coronary Ischemic Event

    Oct 1, 2017, 00:00

  • Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients with and Without Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Between-Hospital Variation of In-Hospital Mortality and 30-Day Readmissions in Acute Myocardial Infarction in Portugal- 2012-2014

    Oct 1, 2017, 00:00

  • Adesão A Terapia Antihipertensiva E Qualidade De Vida

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Haploidentical Vs Matched Unrelated Allogeneic Hematopoietic Stem Cells Transplantation in Patients Older Than 55 Years

    Oct 1, 2017, 00:00

  • Treatment Satisfaction and Burden of Illness With Oral Vs Injectable Multiple Myeloma Therapy in Patients with Newly Diagnosed Disease (NDMM)

    Oct 1, 2017, 00:00

  • Impairment of Work Ability In Patients With Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Rare Diseases, Are Caregivers Just As Affected As Patients?

    Oct 1, 2017, 00:00

  • Market Dynamics of Statin Medications

    Oct 1, 2017, 00:00

  • Patient and Tumor Profiles in The Brazilian Private Setting- Data from The Auditron Claims Database

    Oct 1, 2017, 00:00

  • Economic Burden Associated with Skeletal-Related Events in Patients with Bone Metastases in Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Molecular Versus Conventional Screening For Acute Intestinal Infectious Diseases- Novel Application Of Agent-Based Modelling

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Obinutuzumab Plus Chlorambucil in Patients with Previously Untreated Chronic Lymphocytic Leukemia and Coexisting Conditions

    Oct 1, 2017, 00:00

  • The Economic Burden of Different Multiple Sclerosis Phenotypes

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis of Obinutuzumab In The Management of Chronic Lymphocytic Leukemia In Greece

    Oct 1, 2017, 00:00

  • A Novel Atrial Fibrillation Evaluation Modelling Solution For NHS

    Oct 1, 2017, 00:00

  • Is Willingness to Pay Higher for Cancer Prevention and Treatment?

    Oct 1, 2017, 00:00

  • Calibrating Model-Consistent Transition Probabilities For Fibrosis Stages In NASH

    Oct 1, 2017, 00:00

  • The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions

    Oct 1, 2017, 00:00

  • Tratamento Clínico De Obesidade Através De Internações Clínicas Em Spa- Impacto Econômico Da Judicialização

    Oct 1, 2017, 00:00

  • Alemtuzumab Is The Most Cost-Effective Option In Comparison To Available Therapies In The Treatment of Rrms From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • An Effective Tablet Program For Collecting Pain Data From Patients

    Oct 1, 2017, 00:00

  • Economic Evaluation of Single Inhaler Triple Therapy For Patients With Chronic Obstructive Pulmonary Disease (COPD) Using The Galaxy Model

    Oct 1, 2017, 00:00

  • A Systematic Review of Corticosteroids’ Role in the Management of Urolithiasis Patients

    Oct 1, 2017, 00:00

  • Assessment of Antidiabetic Drugs In Fran What Is The Basis For A Reimbursement Recommendation?

    Oct 1, 2017, 00:00

  • Do Nice Appeals Make A Difference? Impact of Appeals on Appraisal Outcomes

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey

    Oct 1, 2017, 00:00

  • Assessing the Value of Decision Trees As A Method for Identifying Patient Subgroups

    Oct 1, 2017, 00:00

  • Health Technology Assessment Decisions in Immuno-Oncology Therapies- Results, Rationales, and Trends

    Oct 1, 2017, 00:00

  • Investigating Comparator Requirements For Drug Selection For Cost-Effectiveness

    Oct 1, 2017, 00:00

  • A UNIFORM PROBABILISTIC APPROACH TO MANAGE UNCERTAINTIES REGARDING VACCINE EFFECTIVENESS AGAINST SEROTYPE 3, 19A, NTHI AND HERD EFFECT IN THE BASE CASE OF A COST-EFFECTIVENESS ANALYSIS COMPARING NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D ...

    Oct 1, 2017, 00:00

  • Attitude Of Pharmacy Educators Towards Complementary And Alternative Medicines (CAM) Education In Pharmacy Curriculum- A Qualitative Exploration

    Oct 1, 2017, 00:00

  • Minimizing Bias In Indirect Comparisons Utilizing Virtual Patient Level Data

    Oct 1, 2017, 00:00

  • Safety And Effectiveness of Insulin Analogues Versus Human Insulin In Type 2 Diabetes; A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Determinants Of The Relationship Between Improved Glucose Control And Modeled Health Outcomes In Type 2 Diabetes Simulation Models

    Oct 1, 2017, 00:00

  • Burden Of Disease, Healthcare Pathways And Costs Of Primary Progressive Multiple Sclerosis- An Italian Real World Study On 10 Million Inhabitants

    Oct 1, 2017, 00:00

  • Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Burden of Lysosomal Acid Lipase Deficiency

    Oct 1, 2017, 00:00

  • Implementation of Nice Guidance for the Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Antimalarial Treatment Outcomes In Ethiopia- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns Of Patients With Ovarian Cancer Receiving First Line Chemotherapy In The United States

    Oct 1, 2017, 00:00

  • Barriers to the Introduction of Actual Technologies for Induction of Labor Management

    Oct 1, 2017, 00:00

  • Estimation Of The Cost Of Relapse In Schizophrenia- A Comparison Between Colombia, Panama And Mexico

    Oct 1, 2017, 00:00

  • Review of Rare Disease Registries Across EU5 Countries

    Oct 1, 2017, 00:00

  • Redets. 10 Years Of Full Economic Health Technologies Assessments (Medical Devices) In Spain (2006-2016)

    Oct 1, 2017, 00:00

  • A Comparison Of Systemic Pediatric Fluoroquinolone Use In South Korea

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of An Increased Uptake of Alemtuzumab From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • The Impact Of The Study Design Submitted For The Early Benefit Assessment On The Pricing For Oncologic Drugs

    Oct 1, 2017, 00:00

  • The Utility of Different Approachs to Developing Health Utilities Data in Childhood Rare Diseases – A Case Study in Spinal Muscular Atrophy (SMA)

    Oct 1, 2017, 00:00

  • Systematic Review of Herpes Zoster Epidemiology- Available Evidence In Spain Related To Specific Sub-Populations

    Oct 1, 2017, 00:00

  • Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • The Use of Published Real-World Evidence In HTA- An Analysis Of The Evidence Base Of Company Submissions In 2016 Nice Appraisals

    Oct 1, 2017, 00:00

  • Effect Of Hesperidin In Bleomycin-Induced Pulmonary Fibrosis In Rats- Critical Role Of NRF-2, TNF-Α, AND IL-1Β

    Oct 1, 2017, 00:00

  • Evaluating The Economic Burden And Health Care Utilization Of Bacterial Pneumonia In The US Department Of Defense Population

    Oct 1, 2017, 00:00

  • Surveillance Status, Diagnostic Accuracy And Survival Of The National Liver Cancer Surveillance Program

    Oct 1, 2017, 00:00

  • The Occurrence and Territorial Distribution of Acute Myocardial Infarctions in Hungary

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Stereotaxic Eeg (SEEG) As A Preoperative Diagnostic Procedure In Epilepsy Surgery

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Polypill for Patients with or at High Risk of Cardiovascular Disease in an NHS Setting

    Oct 1, 2017, 00:00

  • South West Icers – The Experience of Nice’s Diagnostics Assessment Programme

    Oct 1, 2017, 00:00

  • The Impact of Rheumatoid Arthritis (RA) on a Patient’s Ability to Stay in Work and Level of Pain Experienced

    Oct 1, 2017, 00:00

  • Estudos Econômicos De Belimumabe No Tratamento Do Lúpus Eritematoso Sistêmico - Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • The Attitude Of Parents To Non-Mandatory Vaccinations

    Oct 1, 2017, 00:00

  • Real World Evidence In Europe - The Results Of An Expert Survey

    Oct 1, 2017, 00:00

  • Barreras Y Facilitadores Para La Cobertura De Peritoneodiálisis En Chile

    Oct 1, 2017, 00:00

  • Effect of Acrylic Monofocal Intraocular Lenses (IOLS) on ND-YAG Laser Capsulotomy Rates- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Qualitative Interviews To Inform Development Of A Patient Reported Outcome (PRO) Strategy In RLBP1 Retinitis Pigmentosa (RLBP1 RP)

    Oct 1, 2017, 00:00

  • Non Adherence to Inhalational Medications and Associated Factors Among Patients with Asthma in A Referral Hospital in Ethiopia, Using Validated Tool Tai

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Regimens for Treating Plasmodium Falciparum Malaria- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Skin-Based Temperature Measuring With Different Thermometer Types

    Oct 1, 2017, 00:00

  • Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database

    Oct 1, 2017, 00:00

  • Efetividade Na Solicitação De Exames Laboratoriais Na Atenção Básica

    Oct 1, 2017, 00:00

  • EQ-5D-5L Utility Values For Spanish Patients With Painful Chronic Osteoarthritis, Low-Back-Pain Or Cancer Pain

    Oct 1, 2017, 00:00

  • Costs of Clinical Events in Diabetes Type 2 Patients in the Netherlands- A Systematic Review

    Oct 1, 2017, 00:00

  • Quality of Life (QOL), Functional Status (FS), and Survival in Triple Negative Breast Cancer (TNBC)- Discordance of Definitions Among a Targeted Literature Review and Stakeholder Interviews

    Oct 1, 2017, 00:00

  • Lower Hemoglobin (HB) Levels Negatively Impact Quality Of Life (QOL) Among Peritoneal Dialysis (PD) Patients- Results From A National Representative Cohort Study In Brazil (BRAZPD)

    Oct 1, 2017, 00:00

  • Age and Gender Relationships with Systemic Corticosteroid Induced Morbidity in Asthma- A Case-Control Study

    Oct 1, 2017, 00:00

  • The Research And Suggestions On The Accessibility Of High Value Drugs In China

    Oct 1, 2017, 00:00

  • Study Of Polypharmacy At A Tertiary Care Teaching Hospital Bangalore

    Oct 1, 2017, 00:00

  • Reliability Testing Of The Finnish Version Of The Non-Technical Skills Scale For Trauma (T-Notechs)

    Oct 1, 2017, 00:00

  • Evaluating Patient Reported Outcomes Commonly Used In Current Lung Cancer Clinical Trials

    Oct 1, 2017, 00:00

  • Statistical Trend Analysis of German Benefit Ratings And Their Correlation With Negotiated Rebates Focusing on Orphan Oncologics

    Oct 1, 2017, 00:00

  • Costs And Effectiveness Of An Integrated Care Intervention For Muscle-Skeletal Diseases Transition From Primary Care To Specialized Hospital Care

    Oct 1, 2017, 00:00

  • The Economic Burden of Breast Cancer in Russia

    Oct 1, 2017, 00:00

  • How well does the leading pharmaceutical reform model work in china? --an interrupted time series analysis

    Oct 1, 2017, 00:00

  • Primary Prevention of Hyperlipidemia- Treatment and Compliance in Real World Practice

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia

    Oct 1, 2017, 00:00

  • Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in Europe

    Oct 1, 2017, 00:00

  • Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial

    Oct 1, 2017, 00:00

  • Risk-Stratified Breast Cancer Screening and Non-Adherence in Germany

    Oct 1, 2017, 00:00

  • Systematic Literature Review For Treatment Outcomes (Including Immuno-Oncology Treatment) Among Patients with Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Elasticidad Precio De La Demanda Para Explorar Medidas Impositivas Que Desalienten EL Consumo De Bebidas Azucaradas Y Contribuyan a Prevenir Obesidad Y Diabetes Tipo II

    Oct 1, 2017, 00:00

  • Meta-Análise De Eficácia Da Atomoxetina Em Adultos com Transtorno De Déficit Da Atenção Com Hiperatividade

    Oct 1, 2017, 00:00

  • The Evaluation Of Assumptions In Cost-Effectiveness Model Development – A Case Of Dabigatran

    Oct 1, 2017, 00:00

  • Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark

    Oct 1, 2017, 00:00

  • Multiple Source of Information to Characterize the Clinical, Therapeutic Management and Economic Burden of Patients with Multiple Sclerosis in France

    Oct 1, 2017, 00:00

  • Real-World Prevalence Of Mild To Moderate Hypoglycemic Events In Portugal - Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Adherence to Anti-Convulsant Therapy Among Ambulatory Epileptic Patients in a Tertiary Hospital in Nigeria

    Oct 1, 2017, 00:00

  • A Web-Based Hub Spoke Model For The Management Of HCV Patients And Innovative Treatments- The Resist - HCV Sicily Network Experience

    Oct 1, 2017, 00:00

  • Health Related Quality Of Life For Systemic Juvenile Idiopathic Arthritis (SJIA) Patients And Caregivers On Biologic Therapy, From A Caregiver’s Perspective

    Oct 1, 2017, 00:00

  • Managed Access Agreements (MAAS) In Appraisals Conducted By The National Institute For Health and Care Excellence (NICE)

    Oct 1, 2017, 00:00

  • Incidence of Respiratory Syncytial Virus Related Healthcare Utilization In The United States

    Oct 1, 2017, 00:00

  • Burden and Cost of Cancer Treatment in the Private Healthcare Setting in São Paulo State

    Oct 1, 2017, 00:00

  • Centralized Procurement of Medical Devices In Italy- A Methodology Towards Standardized Tender Dossier

    Oct 1, 2017, 00:00

  • Do People With Private Health Insurance Attach A Higher Value To Health Than Those Without Insurance? Results From An EQ-5D-5L Valuation Study In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • Outcomes of Disease Activity In Rheumatoid Arthritis and Health Insuran Results From Real World

    Oct 1, 2017, 00:00

  • Agreement Between Patient And Clinician Ratings Of Disease Severity In Hidradenitis Suppurativa, Rheumatoid Arthritis, And Chronic Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Cost of Type 2 Diabetes Management And Associated Complications In Spain

    Oct 1, 2017, 00:00

  • National Survey Of Medication Safety Practice At Ministry Of Health Hospitals During Mass Gathering (Hajj-2016) In Saudi Arabia

    Oct 1, 2017, 00:00

  • Gender Differences In Heart Failure- The Arno Italian Experience

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China

    Oct 1, 2017, 00:00

  • Development of A New Patient-Reported Outcome Instrument To Evaluate Treatments For Stretchmarks- The Body-Q Stretchmark Scale

    Oct 1, 2017, 00:00

  • Transsexual’s Sex Reassigment Process In Brazilian National Health System- Where Are We?

    Oct 1, 2017, 00:00

  • Acceptance Of Indirect Comparisons In The German Early Benefit Assessment

    Oct 1, 2017, 00:00

  • Patient Reported Outcome Of Celiac Disease

    Oct 1, 2017, 00:00

  • The Influence Of Pharmaceutical Reform In Korea A Decade Ago- What We Walked

    Oct 1, 2017, 00:00

  • Analysis Of The Reimbursement Amount And The Actual Costs For Infusion Of Immunobiologics In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Quality of Life of Asthma Patients In Gree What Can We Do to Improve It?

    Oct 1, 2017, 00:00

  • Financial Group Incentives Improving Medication Persistence - Health Behavior Engineering Approach

    Oct 1, 2017, 00:00

  • Cost Study Of Immune Thrombocytopenia (ITP) Management From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Preoperative Smoking Cessation- Recording of Smoking Status in the Porvoo Hospital Area in Finland

    Oct 1, 2017, 00:00

  • The Impact Of Patient Preference Studies In The German Healthcare System

    Oct 1, 2017, 00:00

  • Assessment of Hiv-Antiretroviral Adherence Using Refill Data From a National Administrative Database in Brazil

    Oct 1, 2017, 00:00

  • Beyond Product Value - A Holistic Approach For Value Assessment

    Oct 1, 2017, 00:00

  • FOLLOW-UP OF PEDIATRIC PATIENTS UNDER TREATMENT WITH SOMATROPIN IN BRAZIL THROUGH A PATIENT SUPPORT PROGRAM (PSP)

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In Metastatic And/Or Unresectable Gastric Cancer Patients In Russia

    Oct 1, 2017, 00:00

  • Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

    Oct 1, 2017, 00:00

  • Understanding Patients’ Ability to Function in Order to Inform Clinical Benefit in Oncology Studies

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Intermediate Risk Patients In France

    Oct 1, 2017, 00:00

  • Strategies To Effectively Prevent Surgical Site Infections In Italian Hospitals- Economic Benefits

    Oct 1, 2017, 00:00

  • Economic Analysis And Evaluation Of The Value Of The Parallel Export Of Medicinal Products For Treatment Of Oncological Diseases In Bulgaria, 2016 T. VEKOV 1 AND G. KOLEV2

    Oct 1, 2017, 00:00

  • Factors Influencing Innovative Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Análise Situacional Do Tratamento Cirúrgico Do Câncer Colorretal No Brasil

    Oct 1, 2017, 00:00

  • Cognitive Interviewing During Linguistic Validation Of Clinical Outcomes Assessments (COAS)- In-Person Or Video Chat – An Analysis Of Respondent Preference

    Oct 1, 2017, 00:00

  • New Insights In Metastatic Colorectal Cancer Treatment (MCRC) In 5 European Countries

    Oct 1, 2017, 00:00

  • Denosumab And Bisphosphonates Persistence, Compliance And Switch In Patients With Solid Tumors (ST) And Bone Metastases (BM)

    Oct 1, 2017, 00:00

  • Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada

    Oct 1, 2017, 00:00

  • GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA

    Oct 1, 2017, 00:00

  • Increasing Trend On Turkish Un-Licenced Medicine Market- A General Overview Analysis

    Oct 1, 2017, 00:00

  • Using Rasch Measurement To Quantify The Perceived Risks Associated With The Use Of Tobacco And Nicotine-Containing Products

    Oct 1, 2017, 00:00

  • Epidemiology and Clinical Characterisation of Obsessive- Compulsive Disorder in Bahawalpur Pakistan

    Oct 1, 2017, 00:00

  • Finding The Patient In Clinical Meaningfulness Through Rigorous Cognitive Interviews

    Oct 1, 2017, 00:00

  • Competency Analysis Of Community Pharmacists About Correct Use Of Metered Dose Inhaler

    Oct 1, 2017, 00:00

  • Factors Contributing To The National Drug Expenditure Of Korea, 2010-2015- Focusing On The Core Therapeutic Classes

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Results Of Highly Innovative Drugs Approved For Temporary Reimbursement In The Czech Republic

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Nivolumab for The Treatment of People with Relapsed or Refractory Classical Hodgkin Lymphoma Following Autologous Stem Cell Transplant and Brentuximab Vedotin

    Oct 1, 2017, 00:00

  • Comparison of The Quality of Life In Elderly Population According To The Occurrence of Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Análisis De Costo-Efectividad De La Monoterapia Con Rasagilina Comparada Con Pramipexol Para EL Manejo De Los Síntomas Motores En Pacientes Con Enfermedad De Parkinson Inicial En Colombia

    Oct 1, 2017, 00:00

  • Choice of Instrument Impacts Healthcare Decisions- Effect of Source of Utility Derived from the Same Patient Population on Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns And Resource Use For Advanced Non-Small Cell Lung Cancer In Brazilian Private Institutions

    Oct 1, 2017, 00:00

  • The Burden of Spondyloarthritis – Paasport A Population-Based Study

    Oct 1, 2017, 00:00

  • Retrospective Study On Italian Adpkd Disease Management Cost (REINA STUDY)

    Oct 1, 2017, 00:00

  • Evolution Cost-Effectiveness Analysis of Pharmaceutical Care for Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Effect of Health System, Financing, and Macro-Economic Characteristics on The Migration of Foreign Physicians To Oecd Countries

    Oct 1, 2017, 00:00

  • Review of Surrogate Endpoint Validation Methodologies and Application In Solid Tumour Htas

    Oct 1, 2017, 00:00

  • The Prevalence and Treatment Status of Different Multiple Sclerosis Phenotypes in a Italian Reference Center

    Oct 1, 2017, 00:00

  • Identification of Real World Data Sources in Cancer in the Nordic Countries

    Oct 1, 2017, 00:00

  • Evidence Map of Indirect Costs In Psoriasis and Psoriatic Arthritis Since 1960

    Oct 1, 2017, 00:00

  • Substantiation of the National Policy of Pricing and Availability of Drugs

    Oct 1, 2017, 00:00

  • Validation of Surrogate Endpoints In Melanoma Therapies and Use In HTA

    Oct 1, 2017, 00:00

  • Disease Progression in Pediatric Multiple Sclerosis- A Narrative Review

    Oct 1, 2017, 00:00

  • Economic Evaluation of Exemestane Versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer from The Egyptian Health Care System Perspective

    Oct 1, 2017, 00:00

  • Minimally Important Differen Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

    Oct 1, 2017, 00:00

  • Ameliorative Effect of Morin, A Bioflavonoid on Freund’s Adjuvant induced Established Polyarthritis in Rats

    Oct 1, 2017, 00:00

  • The Prevalence Of Chronic Health Conditions And Multimorbidity In The Portuguese Population - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of four Surgical Strategies for the Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • Vaccines for Herpes Zoster- A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age

    Oct 1, 2017, 00:00

  • Comparison Of Food And Drug Administration, European Medicine Agency And Swissmedic New Drug Approval- An Assessment Of The International Harmonization

    Oct 1, 2017, 00:00

  • The Budget Impact Of Introducing A PD-L1 Assay To Select Patients With Metastatic Nsclc Who Are Potential Candidates For Treatment With Immune Checkpoint Inhibitors

    Oct 1, 2017, 00:00

  • An Economic Evaluation Of Single Tablet Regimens Of Antiretroviral Therapy For Treatment-Naitve Hiv-Infected Patients

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulant (DOAC) Adoption in Practi Utilization, Expenditures, Switching and Adherence

    Oct 1, 2017, 00:00

  • Access and Secondary Use of Data Collected In An Electronic Medical Chart- Results Of The Real World Roswitch Study

    Oct 1, 2017, 00:00

  • Achieving Key Objectives In Rare Diseases Healthcare Policy In Spain- Contribution From A Dravet Syndrome Working Group

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared to Conventional Treatment From A Societal Perspective In Germany, France, Italy And The UK

    Oct 1, 2017, 00:00

  • Trends in Pragmatic Clinical Trials

    Oct 1, 2017, 00:00

  • The Use of Mcda In HTA Decision Making In Bulgaria

    Oct 1, 2017, 00:00

  • Linguistic Validation Of Knowledge, Attitudes And Practice Of Zika Virus Disease Questionnaire Among The Malaysian General Public Using Rasch Model- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab

    Oct 1, 2017, 00:00

  • Value Of Treating All Liver Fibrosis Stages To Reach Elimination Of Diagnosed Chronic Hepatitis C- A Modelling Approach In France

    Oct 1, 2017, 00:00

  • Community Pharmacists' Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation- 3-Year Financial Projections For Three UK Regions

    Oct 1, 2017, 00:00

  • Burden of Disease on Chronic Heart Failure Patients- A Multinational Cross-Sectional Survey in Real World Setting

    Oct 1, 2017, 00:00

  • Development Of A Tool To Quantify An Individual’s History Of Sun Exposure- Qualitative Phase Of The Development Of The Sun Exposure Questionnaire

    Oct 1, 2017, 00:00

  • Drug Utilization in a Cardiology Unit of a Referral Hospital in Nigeria

    Oct 1, 2017, 00:00

  • Early Access To Medicines Pathways – Results Of A Global Survey

    Oct 1, 2017, 00:00

  • The Comparative Cost-Effectiveness of Cabozantinib, Everolimus and Axitinib in Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy- Scottish Perspective

    Oct 1, 2017, 00:00

  • Varying Nature Of The Assessment Of Advanced Medicinal Products (Atmp) In Germany

    Oct 1, 2017, 00:00

  • Un Marco Conceptual Para El Análisis De La Implementación De Los Componentes De La Salud Electrónica (E-Salud) Y Su Efecto En La Calidad En La Provisión De Servicios De Salud

    Oct 1, 2017, 00:00

  • Drugprice Developments After Patent Expiry

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino EN EL Sector Público De Argentina

    Oct 1, 2017, 00:00

  • Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Treatments For Hepatitis C Virus- What’s New?

    Oct 1, 2017, 00:00

  • The Economic Impact of Optimizing Therapy In ‘Hard-To-Treat’ and ‘Harder-To-Treat’ Hypothyroid Patients by Changing the Levothyroxine Formulation from Tablets to Gel Caps

    Oct 1, 2017, 00:00

  • An Analysis of Translation Challenges When Adapting The Picture Naming Subtest of The Repeatable Battery for The Assessment of Neuropsychological Status (RBANS) for Use In Multinational Studies

    Oct 1, 2017, 00:00

  • Differences In Vaccine Pricing Between High-Income And Low-Income Markets

    Oct 1, 2017, 00:00

  • Economic Evaluation of Strategies for Opportunistic Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Investigating The Economic Impact Of HIV-Associated Renal And Bone Co-Morbidities In UK Inpatients Using The Hes Database

    Oct 1, 2017, 00:00

  • Patient-Preferred Design Features Of Tnf Inhibitor Self-Injection Devices- Insights From A Rheumatoid Arthritis Auto-Injector Preference Study

    Oct 1, 2017, 00:00

  • Value Communication Strategies for Immunotherapies in Nsclc- A Quick Evidence Assessment from The UK

    Oct 1, 2017, 00:00

  • Epidemiology of Locally Advanced or Metastatic Urothelial Cancer In The US, Europe And Japan

    Oct 1, 2017, 00:00

  • Budget Impact Model of Secukinumab for Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis Treatment in Italy

    Oct 1, 2017, 00:00

  • Expenditure On Non-Pharmaceutical Products In Ireland During A Period Of Healthcare Cost Containment

    Oct 1, 2017, 00:00

  • Anticonvulsant Drugs Use Evaluation Survey Among Ambulatory Epileptic Patients In A Tertiary Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • An Evaluation Of The Budget Impact Of The New 20% Subcutaneous Immunoglobulin (IG20GLY) For The Management Of Primary Immunodeficiency Diseases In Switzerland

    Oct 1, 2017, 00:00

  • Infection Prevention In Heart Surgery In Germany- An Economic Analysis

    Oct 1, 2017, 00:00

  • Situation of Rheumatoid Arthritis Patients Treated with Biologics In Germany Based on a Claims Data Analysis

    Oct 1, 2017, 00:00

  • Outcomes And Costs Of Treating Hepatitis C With Direct-Acting Antivirals- Results From The German Hepatitis C-Registry

    Oct 1, 2017, 00:00

  • Comprehensive Knowledge and Uptake of Cervical Cancer Screening is Low Among Women Living with HIV/AIDS in Northwest Ethiopia

    Oct 1, 2017, 00:00

  • 20th Euro - FDS Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • Aplicação Da Mcda Nas Tomadas De Decisão Sobre Investimento Em Saúde – Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • Determining The Comparative Value Of Outcome-Based Money-Back Guarantee Scenarios In Non-Small Cell Lung Cancer Using Real-World Data

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico

    Oct 1, 2017, 00:00

  • The FDA Approval of Eteplirsen – Necessary Flexibility or a Worrying Precedent?

    Oct 1, 2017, 00:00

  • Impact of Collaborative Coustomized Patient Education in Psychiatric Diseases

    Oct 1, 2017, 00:00

  • A Comparative Study Between Hypertensive Patients with and without Co-Morbidities; Knowledge, Acceptance of Illness and Quality of Life as Quantifiable Variables in KPK, Pakistan

    Oct 1, 2017, 00:00

  • Quality Of Life In Patients With Knee Arthritis In Slovak Republic

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Oral Glycopyrronium Bromide (Sialanar™) For The Symptomatic Treatment of Severe Sialorrhoea (DROOLING) In The UK Setting

    Oct 1, 2017, 00:00

  • Value Health With A Mobile APP- The Infant Health-Related Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In The Neurogenic Bladder Population- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Development And Evaluation Of Onconurse Practice− A Smartphone Application For Oncology Nurses

    Oct 1, 2017, 00:00

  • The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments

    Oct 1, 2017, 00:00

  • Variation In Opioid Utilization By Physician Specialty And Payer Using A Linked Claims-Emr Database

    Oct 1, 2017, 00:00

  • Crohn’s Disease in Germany- A Claims Data Analysis of Therapies with Biological Agents

    Oct 1, 2017, 00:00

  • Utility Values Across Lines of Therapy in Immuno-Oncology Treatments- An Example from Advanced Melanoma

    Oct 1, 2017, 00:00

  • Economic Effectiveness Of The Attune® Knee System - Analysis Of Real World Hospital Length Of Stay And Incidence Of Early Complications

    Oct 1, 2017, 00:00

  • The Impact Of Co-Morbidity On The Disease Burden Of VTE

    Oct 1, 2017, 00:00

  • Real World Effectiveness of Treatment With OBV/PTV/R ± DSV In HCV Patients With Cirrhosis In Poland

    Oct 1, 2017, 00:00

  • Haemorrhoidal Artery Ligation Procedure For The Treatment of Symptomatic Grade II–III Heamorrhoids- A Trial-Based And Long-Term Model-Based Economic Evaluation

    Oct 1, 2017, 00:00

  • Pharmacological Adherence to Clinical Guidelines in Acute Coronary Syndrome in Hospitals

    Oct 1, 2017, 00:00

  • Will It Blend? Incorporation Of IRP Within HTA Systems

    Oct 1, 2017, 00:00

  • Cost Containment And Privatisation Of Pharmaceutical Care In Gree A Review Of Policy Reforms Under The Memorandums’ Requirements

    Oct 1, 2017, 00:00

  • Estimating The Impact of Strategies For Cervical Cancer Prevention And Control In Indonesia Using Markov Model

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- A Person Trade Off Study

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68 (current)
  • 69
  • 70
  • »